Cargando…
Prognostic Role of Survivin and Macrophage Infiltration Quantified on Protein and mRNA Level in Molecular Subtypes Determined by RT-qPCR of KRT5, KRT20, and ERBB2 in Muscle-Invasive Bladder Cancer Treated by Adjuvant Chemotherapy
Objectives: Bladder cancer is a heterogeneous malignancy. Therefore, it is difficult to find single predictive markers. Moreover, most studies focus on either the immunohistochemical or molecular assessment of tumor tissues by next-generation sequencing (NGS) or PCR, while a combination of immunohis...
Autores principales: | Ecke, Thorsten H., Kiani, Adisch, Schlomm, Thorsten, Friedersdorff, Frank, Rabien, Anja, Jung, Klaus, Kilic, Ergin, Boström, Peter, Tervahartiala, Minna, Taimen, Pekka, Gleichenhagen, Jan, Johnen, Georg, Brüning, Thomas, Koch, Stefan, Roggisch, Jenny, Wirtz, Ralph M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7582791/ https://www.ncbi.nlm.nih.gov/pubmed/33050010 http://dx.doi.org/10.3390/ijms21197420 |
Ejemplares similares
-
Prediction of Response to Cisplatin-Based Neoadjuvant Chemotherapy of Muscle-Invasive Bladder Cancer Patients by Molecular Subtyping including KRT and FGFR Target Gene Assessment
por: Ecke, Thorsten H., et al.
Publicado: (2022) -
Evaluation of a New Survivin ELISA and UBC(®)
Rapid for the Detection of Bladder Cancer in Urine
por: Gleichenhagen, Jan, et al.
Publicado: (2018) -
Exploring solid-phase proximity ligation assay for survivin detection in urine
por: Gleichenhagen, Jan, et al.
Publicado: (2022) -
Analysis of KRT1, KRT10, KRT19, TP53 and MMP9 expression in pediatric and adult cholesteatoma
por: Palkó, Enikő, et al.
Publicado: (2018) -
KRT20, KRT5, ESR1 and ERBB2 Expression Can Predict Pathologic Outcome in Patients Undergoing Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Bladder Cancer
por: Jütte, Hendrik, et al.
Publicado: (2021)